Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.870
-0.120 (-6.03%)
At close: Sep 12, 2025, 4:00 PM EDT
1.898
+0.028 (1.51%)
After-hours: Sep 12, 2025, 7:37 PM EDT
Equillium Market Cap
Equillium has a market cap or net worth of $111.27 million as of September 12, 2025. Its market cap has increased by 202.03% in one year.
Market Cap
111.27M
Enterprise Value
100.04M
1-Year Change
202.03%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $111.27M, a decrease of -52.56%. That is a compound annual growth rate of -10.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 111.27M | 319.74% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | 132.29M | 125.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |